BioMarin Pharmaceutical, headquartered in San Rafael, California, develops therapies for serious rare diseases and employs 3,401 people. Its products include Vimizim, Roctavian, and Voxzogo for various medical conditions.
BMRN filed a patent for "methods of treating anti-aav seropositive hemophilia patients" on Mon, May 15, 2023.
📡️ Health Care
Patents
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
